Search research articles
Contact Us
Filters
Showing results (231-240 of 281) with videos related to
Page
of 29
Sort By:
Cancer Immunology Research
|
November 15, 2018
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
Sabrina A Hogan, Anaïs Courtier, Phil F Cheng, et al.
The EMBO Journal
|
July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanoma
Verena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 6, 2024
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma
Karlijn de Joode, Alfonso Rojas Mora, Ron H N van Schaik, et al.
Med (New York, N.Y.)
|
April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma
Ramona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Archives of Dermatological Research
|
October 1, 2024
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age
Ion Birkenmaier, Lara Valeska Maul, Iker Oyanguren, et al.
Cancer Research
|
February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma
Joanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
The EMBO Journal
|
May 8, 2024
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification
Roma Parikh, Shivang Parikh, Daniella Berzin, et al.
Science (New York, N.Y.)
|
October 25, 2008
Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root
Ive De Smet, Valya Vassileva, Bert De Rybel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor
Jürgen Wichmann, Caroline Rynn, Thomas Friess, et al.
Molecular Cancer Research : MCR
|
April 18, 2023
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 281) with videos related to
Sort By:
Page
of 29
Cancer Immunology Research
|
November 15, 2018
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
Sabrina A Hogan, Anaïs Courtier, Phil F Cheng, et al.
The EMBO Journal
|
July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanoma
Verena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 6, 2024
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma
Karlijn de Joode, Alfonso Rojas Mora, Ron H N van Schaik, et al.
Med (New York, N.Y.)
|
April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma
Ramona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Archives of Dermatological Research
|
October 1, 2024
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age
Ion Birkenmaier, Lara Valeska Maul, Iker Oyanguren, et al.
Cancer Research
|
February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma
Joanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
The EMBO Journal
|
May 8, 2024
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification
Roma Parikh, Shivang Parikh, Daniella Berzin, et al.
Science (New York, N.Y.)
|
October 25, 2008
Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root
Ive De Smet, Valya Vassileva, Bert De Rybel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor
Jürgen Wichmann, Caroline Rynn, Thomas Friess, et al.
Molecular Cancer Research : MCR
|
April 18, 2023
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld, et al.
Page
of 29